HEART FAILURE WITH MID RANGE EJECTION FRACTION
Clinical trials for HEART FAILURE WITH MID RANGE EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH MID RANGE EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH MID RANGE EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes pill ease rare heart condition?
Disease control CompletedThis study tested the drug dapagliflozin (a diabetes medicine) in 50 adults with heart failure due to amyloid cardiomyopathy, a rare condition where abnormal proteins stiffen the heart. Researchers measured changes in quality of life, walking ability, and heart stress levels over…
Matched conditions: HEART FAILURE WITH MID RANGE EJECTION FRACTION
Phase: NA • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
New MRI test may detect rare heart disease without a biopsy
Diagnosis CompletedThis study tested a special heart MRI technique called T1 mapping to see if it can accurately diagnose cardiac amyloidosis, a condition where abnormal proteins build up in the heart. Researchers studied 112 older adults with heart failure and thickened heart walls. The goal was t…
Matched conditions: HEART FAILURE WITH MID RANGE EJECTION FRACTION
Sponsor: University of Leipzig • Aim: Diagnosis
Last updated May 13, 2026 16:01 UTC